BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8289967)

  • 41. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia].
    Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S
    Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunological classification of 112 adult acute leukemia patients].
    Dai H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):633-5. PubMed ID: 16200710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biphenotypic acute leukemia. Clinical, morphological, cytochemical and immunophenotypic studies].
    Chen YZ; Lu LH; Huang MQ
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):678-81, 729. PubMed ID: 1726144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemia.
    Koehler M; Behm F; Hancock M; Pui CH
    Leukemia; 1993 Jan; 7(1):41-5. PubMed ID: 8418378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
    Doi T; Sakamaki S; Koike K; Matsunaga T; Kobayashi D; Muramatsu H; Sato T; Watanabe N; Kougo Y; Niitsu Y
    Rinsho Ketsueki; 1996 Aug; 37(8):676-81. PubMed ID: 8827877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Usefulness of monoclonal antibodies for immunophenotyping in leukemia].
    Sagawa K
    Nihon Rinsho; 1992 Jun; 50(6):1209-16. PubMed ID: 1518136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunophenotypes in 115 patients with acute myeloid leukemia by multi-color flow cytometry].
    Wang XB; Yao JX; Zheng JE; Liu J; Li XQ; He YL; Yu JM; Yang J; Wei J; Liu ZP; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):250-3. PubMed ID: 15854286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression.
    Salamone MC; Roisman FR; Santiago J; Satz ML; Fainboim L
    Dis Markers; 1990; 8(5):265-74. PubMed ID: 1707769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphoid-associated antigen expression by acute myeloid leukemia.
    Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunophenotyping analysis of acute undifferentiated leukemia].
    Ezaki K; Shinkai K; Hirano M
    Nihon Rinsho; 1992 Jun; 50(6):1249-54. PubMed ID: 1518141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
    Keyhani A; Huh YO; Jendiroba D; Pagliaro L; Cortez J; Pierce S; Pearlman M; Estey E; Kantarjian H; Freireich EJ
    Leuk Res; 2000 Feb; 24(2):153-9. PubMed ID: 10654451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of immunophenotype of B-lineage acute lymphoblastic leukemia cells by 4-color flow cytometry].
    Wang H; Liu YR; Chen SS; Chang Y; Qin YZ; Li JL; Fu JY; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):137-41. PubMed ID: 12744734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoid-mediated signaling pathways in CD38 antigen expression in myeloid leukemia cells.
    Mehta K; Cheema S
    Leuk Lymphoma; 1999 Feb; 32(5-6):441-9. PubMed ID: 10048416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
    Bradstock K; Matthews J; Benson E; Page F; Bishop J
    Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B-cell prolymphocytic leukemia expressing CD13 antigen.
    Matsushita A; Nagai K; Ishikawa T; Tatsumi E; Ohno Y; Takahashi T
    Int J Hematol; 1994 Aug; 60(2):157-61. PubMed ID: 7524729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dynamic analysis of cell surface markers in acute leukemias unclassified with immunologic criteria].
    Wang L; Zhang M; Song S
    Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):595-7. PubMed ID: 9592352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand.
    Auewarakul CU; Promsuwicha O; U-Pratya Y; Pattanapanyasat K; Issaragrisil S
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):153-60. PubMed ID: 15032399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bi-phenotypic leukemia and hybrid leukemia].
    Aoki S
    Nihon Rinsho; 1992 Jun; 50(6):1255-61. PubMed ID: 1518142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.